Tezaltan Plus Tablets 80/12.5mg

Adult dose

For patients whose blood pressure is not adequately controlled with telmisartan alone, take 1 tablet daily with water, regardless of meals. Since each component's dosage is fixed, it is recommended to adjust each component's dosage individually before switching to this combination. When clinically appropriate, direct conversion from monotherapy to this medication can also be considered. - Telmisartan/Hydrochlorothiazide combination

Child dose

The safety and efficacy of this medication have not been established in pediatric patients under 18 years of age.

This medication can cause serious side effects to the fetus or newborn, especially when taken during the second and third trimesters of pregnancy; thus, it must be discontinued immediately upon confirmation of pregnancy. This medication should not be administered to patients with allergies to specific ingredients or hypersensitivity to sulfonamide drugs, pregnant women in the second and third trimesters, nursing mothers, patients with bile duct obstruction or cholestasis, and patients with severe liver or kidney diseases. Elderly patients, patients with hyperkalemia, patients with liver impairment, or those with specific diseases such as heart valve disease or obstructive hypertrophic cardiomyopathy should take this medication with caution, monitoring for potential excessive lowering of blood pressure. Various side effects may occur with this medication, including dizziness, hypotension, dyspepsia, skin rash, myalgia, changes in blood test results, and rarely, serious allergic reactions or acute lung issues. During treatment, blood pressure, kidney function, and electrolyte levels should be regularly checked for abnormalities, with particular attention to changes in potassium levels. Use of this medication should be avoided during pregnancy, and it is recommended to switch to other safe antihypertensive treatments if planning for pregnancy or if pregnancy is suspected. It is advised that this medication not be taken while breastfeeding; nursing mothers should not use this medication. In case of overdose, symptoms like hypotension, electrolyte imbalance, and dehydration may occur, so it is important to inform medical personnel immediately for appropriate management according to symptoms. This medication is not recommended for patients under 18 years of age, as safety and efficacy have not been established. For elderly patients, careful observation should be made to avoid excessive blood pressure reduction during treatment. This medication should be kept out of the reach of children, and transferring it to another container is not recommended for quality maintenance.

Serious side effects

Urticaria, severe swelling (angioedema), chest tightness, difficulty breathing, cold sweat, pallor, angioedema (potentially fatal), dyspnea, respiratory disorders (including pneumonia and pulmonary edema), liver function abnormalities/liver impairment, jaundice, hepatocellular jaundice, cholestatic jaundice, acute respiratory distress syndrome (ARDS), severe allergic reactions, severe skin reactions, serious neurological symptoms, severe swelling or urination abnormalities, acute kidney failure

Mild side effects

• Dizziness
• diarrhea
• cough
• bronchitis
• pharyngitis
• sinusitis
• anxiety
• depression
• fainting
• sensory disturbances

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture, and it is safe to store at room temperature between 1 and 30 degrees Celsius. By following these storage guidelines, the effectiveness of the medication can be maintained and deterioration can be prevented.

Appearance

Oval-shaped tablets consisting of a white and pink two-layer structure, with possible pink speckles on the white layer.

Package unit

30 tablets (10 tablets PTP X 3)